GRANUFINK femina caps 60 pce

7680651930029 CH-65193 G04BX 05.02.0.
GRANUFINK femina caps 60 pce
GRANUFINK femina caps 60 pce
GRANUFINK femina caps 60 pce
1 / 3
google

Details

Product number
6519301
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
cucurbitae oleum (Cucurbita pepo L. convar. citrullina I. Greb. var. styriaca I. Greb., oleum) 227.3 mg, rhois aromaticae corticis extractum aquosum siccum (Rhus aromatica Aiton, cortex) 56 mg DER: 5-7:1 Auszugsmittel aqua, lupuli floris extractum aquosum siccum (Humulus lupulus L., flos) 18 mg DER: 5.5-6.5:1 Auszugsmittel aqua, glucosum liquidum dispersione desiccatum 24 mg, maltodextrinum, sojae oleum partim hydrogenatum 47 mg, cera flava, int-rac-alpha-tocopherylis acetas, lecithinum, glycerolum (85 per centum), Kapselhülle: gelatina, E 172 (rubrum), E 172 (flavum), E 171, pro capsula.

Articles (1)

Granufink femina, Hartkapseln
Kapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/11/2023
Patient information leaflet
Français
23/11/2023
Patient information leaflet
Italien
23/11/2023
Professional SmPC
Allemand
23/11/2023
Professional SmPC
Français
23/11/2023
Professional SmPC
Italien
23/11/2023

Detailed composition

Substance Quantity Type Category
cucurbitae oleum
227.3 MG Substance Wirkstoff (Principe actif)
rhois aromaticae corticis extractum aquosum siccum
56.0 MG Substance Wirkstoff (Principe actif)
lupuli floris extractum aquosum siccum
18.0 MG Substance Wirkstoff (Principe actif)
glucosum liquidum dispersione desiccatum
24.0 MG Substance HBESI
maltodextrinum
- Substance HNIDK
sojae oleum partim hydrogenatum
47.0 MG Substance HBESI
cera flava
- Substance HNIDK
int-rac-alpha-tocopherylis acetas
- Substance HNIDK
lecithinum
- Substance HNIDK
glycerolum (85 per centum)
- Substance HNIDK
gelatina
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 171
- Substance FNIDK

Authorization holder

Perrigo Schweiz AG

8001 Zürich

Authorization information

Swissmedic authorization number
65193
Drug name
Granufink femina, Hartkapseln
Galenic form
KAHA
ATC Code
G04BX
Authorization status
Z
Dispensation category
D
First authorization
31/08/2015
Authorization expiration date
31/12/9999
IT number
05.02.0.
Domain
Human medicine
Field of application
Traditionell zur Linderung von Beschwerden infolge überaktiver Blase oder Blasenschwäche bei Frauen

Packaging details

Description (FR)
GRANUFINK femina caps 60 pce
Description (DE)
GRANUFINK femina Kaps 60 Stk
Market launch
31/08/2015
Narcotic (BTM)
No

Other packaging sizes

GRANUFINK femina caps 120 pce
120 KAP
View
Buy us a coffee Explore the data